Menu Search
Equities

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GU5:FRA

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Actions
  • Price (EUR)2.04
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change--
  • Beta0.5075
Data delayed at least 15 minutes, as of Feb 11 2026 07:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a China-based company primarily engaged in the business of pharmaceutical and health. The Company operates through four segments. The Great Southern Medicine segment is engaged in the research and development, manufacturing and sales of Chinese and Western patent medicines, chemical active pharmaceutical ingredients, biopharmaceuticals and natural medicines. The Great Health segment is engaged in the production, research and development and sales of beverages, food, health products and other products. The Great Commercial segment is engaged in the wholesale, retail and import and export of pharmaceutical products, medical devices, health products and other products. The Great Medical segment is engaged in the investment in medical services, traditional Chinese medicine health care, modern elderly care and medical device industries. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)87.54bn
  • Net income in HKD3.37bn
  • Incorporated1997
  • Employees28.14k
  • Location
    Guangzhou Baiyunshan Pharmaceutical Holdings Co LtdNo. 45 Shamian North StreetLiwan DistrictGUANGZHOU 510130ChinaCHN
  • Phone+86 2 066281218
  • Fax+86 2 066281229
  • Websitehttps://www.gybys.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.